Key Takeaway: Werewolf Therapeutics has announced its financial results for the second quarter of 2025, along with a business update. The report was released on August 14, 2025, from their headquarters in Watertown, Massachusetts. Details regarding financial performance and future business strategies were included in the announcement.
Price reaction · baseline $1.35 (2025-08-13 close) · hit pre-market · clean, no other HOWL news in the window
day 0 close · peak
-2.2%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+25%
120-day peak, hindsight
Typical move
15%
average across 6 past catalysts
Lead asset
WTX-330
Phase 1 · Advanced or Metastatic Solid Tumors
Full Press Release Details
August 14, 2025
Werewolf Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
WATERTOWN, Mass., August 14, 2025 — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)